Technical Analysis for AERI - Aerie Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 44.78 -1.60% -0.73
AERI closed down 1.6 percent on Tuesday, March 26, 2019, on 56 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical AERI trend table...

Date Alert Name Type % Chg
Mar 26 50 DMA Support Bullish 0.00%
Mar 26 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 26 Bollinger Band Squeeze Range Contraction 0.00%
Mar 26 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 26 Down 3 Days in a Row Weakness 0.00%
Mar 26 Lower Bollinger Band Touch Weakness 0.00%
Mar 25 Fell Below 20 DMA Bearish -1.60%
Mar 25 Bollinger Band Squeeze Range Contraction -1.60%
Mar 25 BB Squeeze + Lower Band Touch Range Contraction -1.60%
Mar 25 Lower Bollinger Band Touch Weakness -1.60%

Older signals for AERI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its product candidates include dual-action AR-13324, a once-daily eye drop to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension, which has completed a Phase IIb clinical trials; triple-action PG324, a single drop fixed-dose combination of AR-13324 and latanoprost for the treatment of patients with glaucoma; and AR-13533, a dual-action ROCK/NET inhibitor that is in preclinical development stage. The company was founded in 2005 and is headquartered in Bedminster, New Jersey.
Chemistry Pharmaceutical Diseases Chemical Compounds Organic Compounds Glaucoma Alcohols Cyclopropanes Aerie Pharmaceuticals Intraocular Pressure Ocular Hypertension Prostaglandins
Is AERI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 74.75
52 Week Low 32.18
Average Volume 724,646
200-Day Moving Average 53.0369
50-Day Moving Average 44.651
20-Day Moving Average 46.7225
10-Day Moving Average 46.741
Average True Range 2.3805
ADX 24.53
+DI 25.1212
-DI 20.1364
Chandelier Exit (Long, 3 ATRs ) 42.9585
Chandelier Exit (Short, 3 ATRs ) 46.6415
Upper Bollinger Band 48.7745
Lower Bollinger Band 44.6705
Percent B (%b) 0.03
BandWidth 8.783777
MACD Line 0.6291
MACD Signal Line 0.9244
MACD Histogram -0.2953
Fundamentals Value
Market Cap 1.63 Billion
Num Shares 36.3 Million
EPS -3.26
Price-to-Earnings (P/E) Ratio -13.74
Price-to-Sales 0.00
Price-to-Book 12.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.47
Resistance 3 (R3) 48.49 47.28 47.86
Resistance 2 (R2) 47.28 46.34 47.27 47.65
Resistance 1 (R1) 46.03 45.75 45.42 46.01 47.45
Pivot Point 44.81 44.81 44.51 44.81 44.81
Support 1 (S1) 43.57 43.87 42.96 43.55 42.11
Support 2 (S2) 42.35 43.29 42.34 41.91
Support 3 (S3) 41.10 42.35 41.70
Support 4 (S4) 41.09